Page last updated: 2024-10-31

midodrine and Weight Loss

midodrine has been researched along with Weight Loss in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Weight Loss: Decrease in existing BODY WEIGHT.

Research Excerpts

ExcerptRelevanceReference
"The objective of the present work was to study the role of midodrine in patients with non-azotemic cirrhosis with tense ascites."9.19Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial. ( Al-Garem, N; Ali, A; Amin, M; Farid, S; Kassem, M, 2014)
"The objective of the present work was to study the role of midodrine in patients with non-azotemic cirrhosis with tense ascites."5.19Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial. ( Al-Garem, N; Ali, A; Amin, M; Farid, S; Kassem, M, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, A1
Farid, S1
Amin, M1
Kassem, M1
Al-Garem, N1

Trials

1 trial available for midodrine and Weight Loss

ArticleYear
Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial.
    Hepato-gastroenterology, 2014, Volume: 61, Issue:135

    Topics: Adrenergic alpha-1 Receptor Agonists; Aged; Ascites; Blood Flow Velocity; Double-Blind Method; Drain

2014